SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-032850
Filing Date
2021-03-05
Accepted
2021-03-05 17:45:39
Documents
1
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm218888d3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm218888d3_4seq1.xml 4 8618
  Complete submission text file 0001104659-21-032850.txt   10190
Mailing Address C/O CELLECTAR BIOSCIENCES, INC. 8383 GREENWAY BLVD STE 600 MIDDLETON WI 53562
Business Address
CARUSO JAMES V (Reporting) CIK: 0001202770 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 21719805

Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations